Dietary and lifestyle interventions should be given to overweight or obese women before they become pregnant to prevent any health risk and improve pregnancy outcomes.

‘Dietary and lifestyle interventions should be given to overweight or obese women prior to pregnancy to avoid any health risk and improve pregnancy outcomes.’
Read More..

The GRoW (Metformin for Gestational Restriction of Weight in pregnant women) trial was designed to reduce risks for pregnant women who are overweight or obese.Read More..





The researchers investigated the potential of the use of common diabetes medication metformin during pregnancy to reduce pregnancy weight gain and improve pregnancy outcomes. Research trials conducted elsewhere previously had conflicting findings.
"In high-income countries, roughly 50% of women are already overweight or obese when they become pregnant," says project leader Professor Jodie Dodd, Professor of Obstetrics and Gynaecology in the University of Adelaide's Robinson Research Institute and maternal-fetal medicine specialist at the Women's and Children's Hospital.
"This places both the mother and her infant at risk of a range of pregnancy and birth outcomes and can also lead to high infant birth weight, which in turn can lead to childhood obesity."
The study enrolled women who were pregnant and overweight or obese; half of the women were given a medication called metformin, usually used for the treatment of type 2 diabetes. All women were given advice on healthy diet and lifestyle.
Advertisements
While Metformin has been used in previous studies of obesity in pregnancy, this study is the first to include women who were overweight, as well as obese, and the first to combine the medication with dietary and lifestyle advice.
Advertisements
"This study supports that outcome. We need to consider dietary and lifestyle interventions prior to women becoming pregnant if we are going to break the cycle of intergenerational obesity."
Source-Eurekalert